Abstract
Purpose: Bevacizumab (Avastin) is a humanized monoclonal antibody approved by the European Medicines Agency for the intravenous treatment of cancer. H......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
